Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Prolonged mechanical ventilation worsens sepsis-induced diaphragmatic dysfunction in the rat.

Le Dinh M, Carreira S, Obert J, Gayan-Ramirez G, Riou B, Beuvin M, Similowski T, Coirault C, Demoule A.

PLoS One. 2018 Aug 1;13(8):e0200429. doi: 10.1371/journal.pone.0200429. eCollection 2018.

2.

Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis-an open-label study.

Ashat M, Lewis A, Liaquat H, Stocker A, McElmurray L, Vedanarayanan V, Soota K, Howell T, Kedar A, Obert J, Abell TL.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13256. Epub 2017 Dec 4.

PMID:
29205691
3.

Tides in the Last Interglacial: insights from notch geometry and palaeo tidal models in Bonaire, Netherland Antilles.

Lorscheid T, Felis T, Stocchi P, Obert JC, Scholz D, Rovere A.

Sci Rep. 2017 Nov 24;7(1):16241. doi: 10.1038/s41598-017-16285-6.

4.

The Association Between Artificial Sweeteners and Obesity.

Pearlman M, Obert J, Casey L.

Curr Gastroenterol Rep. 2017 Nov 21;19(12):64. doi: 10.1007/s11894-017-0602-9. Review.

PMID:
29159583
5.

Popular Weight Loss Strategies: a Review of Four Weight Loss Techniques.

Obert J, Pearlman M, Obert L, Chapin S.

Curr Gastroenterol Rep. 2017 Nov 9;19(12):61. doi: 10.1007/s11894-017-0603-8. Review.

PMID:
29124370
6.

Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease.

Obert J, Freynet O, Nunes H, Brillet PY, Miyara M, Dhote R, Valeyre D, Naccache JM.

Rheumatol Int. 2016 Dec;36(12):1727-1735. Epub 2016 Oct 8.

PMID:
27722793
7.

18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis.

Obert J, Vercellino L, Van Der Gucht A, de Margerie-Mellon C, Bugnet E, Chevret S, Lorillon G, Tazi A.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):598-610. doi: 10.1007/s00259-016-3521-3. Epub 2016 Sep 20.

PMID:
27645693
8.

Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?

Haywood N, Gennaro K, Obert J, Sauer PF Jr, Redden DT, Zarzour J, Smith JK, Bolus D, Saddekni S, Aal AK, Gray S, White J, Eckhoff DE, DuBay DA.

J Oncol. 2016;2016:4692139. doi: 10.1155/2016/4692139. Epub 2016 Feb 2.

9.

Idelalisib-related pneumonitis.

Haustraete E, Obert J, Diab S, Abbes S, Zini JM, Valade S, Lerolle N, Albin N, Arnulf B, Bouaziz JD, Hussenet C, Tazi A, Bergeron A.

Eur Respir J. 2016 Apr;47(4):1280-3. doi: 10.1183/13993003.01670-2015. Epub 2016 Feb 25. No abstract available.

10.

A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype.

Rohnalter V, Roth K, Finkernagel F, Adhikary T, Obert J, Dorzweiler K, Bensberg M, Müller-Brüsselbach S, Müller R.

Oncotarget. 2015 Nov 24;6(37):40005-25. doi: 10.18632/oncotarget.5552.

11.

[Pulmonary manifestations of Langerhans cell histiocytosis].

Obert J, Tazi A.

Rev Mal Respir. 2015 Oct;32(8):850-66. doi: 10.1016/j.rmr.2015.01.005. Epub 2015 May 21. Review. French.

12.

Liver diseases.

Obert J, Cave M, Marsano L.

World Rev Nutr Diet. 2015;111:146-50. doi: 10.1159/000362314. Epub 2014 Nov 17. No abstract available.

PMID:
25418405
13.

Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.

Adhikary T, Brandt DT, Kaddatz K, Stockert J, Naruhn S, Meissner W, Finkernagel F, Obert J, Lieber S, Scharfe M, Jarek M, Toth PM, Scheer F, Diederich WE, Reinartz S, Grosse R, Müller-Brüsselbach S, Müller R.

Oncogene. 2013 Oct 31;32(44):5241-52. doi: 10.1038/onc.2012.549. Epub 2012 Dec 3.

14.

Pneumococcal infections: association with asthma and COPD.

Obert J, Burgel PR.

Med Mal Infect. 2012 May;42(5):188-92. doi: 10.1016/j.medmal.2012.02.003. Epub 2012 Mar 22. Review.

PMID:
22444165
15.

Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics.

Ball SA, Martino S, Nich C, Frankforter TL, Van Horn D, Crits-Christoph P, Woody GE, Obert JL, Farentinos C, Carroll KM; National Institute on Drug Abuse Clinical Trials Network.

J Consult Clin Psychol. 2007 Aug;75(4):556-67. Erratum in: J Consult Clin Psychol. 2009 Apr;77(2):336.

17.

Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.

McNeese-Smith D, Nyamathi A, Longshore D, Wickman M, Robertson S, Obert J, McCann M, Wells K, Wenzel SL.

Am J Drug Alcohol Abuse. 2007;33(3):439-46.

18.
20.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
21.

Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE; National Institute on Drug Abuse Clinical Trials Network.

Drug Alcohol Depend. 2006 Feb 28;81(3):301-12. Epub 2005 Sep 28.

22.

Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response.

Rawson RA, Gonzales R, Obert JL, McCann MJ, Brethen P.

J Subst Abuse Treat. 2005 Sep;29(2):67-74.

PMID:
16135335
23.

When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.

Obert JL, Brown AH, Zweben J, Christian D, Delmhorst J, Minsky S, Morrisey P, Vandersloot D, Weiner A.

J Subst Abuse Treat. 2005 Apr;28(3):231-7.

PMID:
15857723
24.

Cake shrinkage during freeze drying: a combined experimental and theoretical study.

Rambhatla S, Obert JP, Luthra S, Bhugra C, Pikal MJ.

Pharm Dev Technol. 2005;10(1):33-40.

PMID:
15776811
25.

New drying process for lactic bacteria based on their dehydration behavior in liquid medium.

Mille Y, Obert JP, Beney L, Gervais P.

Biotechnol Bioeng. 2004 Oct 5;88(1):71-6.

PMID:
15389487
26.

Composition of grain and forage from corn rootworm-protected corn event MON 863 is equivalent to that of conventional corn (Zea mays l.).

George C, Ridley WP, Obert JC, Nemeth MA, Breeze ML, Astwood JD.

J Agric Food Chem. 2004 Jun 30;52(13):4149-58.

PMID:
15212462
27.

A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.

Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J; Methamphetamine Treatment Project Corporate Authors.

Addiction. 2004 Jun;99(6):708-17.

PMID:
15139869
28.

The composition of grain and forage from glyphosate tolerant wheat MON 71800 is equivalent to that of conventional wheat (Triticum aestivum L.).

Obert JC, Ridley WP, Schneider RW, Riordan SG, Nemeth MA, Trujillo WA, Breeze ML, Sorbet R, Astwood JD.

J Agric Food Chem. 2004 Mar 10;52(5):1375-84.

PMID:
14995149
29.

Incorporating brain research findings into standard treatment: an example using the Matrix Model.

Obert JL, London ED, Rawson RA.

J Subst Abuse Treat. 2002 Sep;23(2):107-13. Review.

PMID:
12220608
30.

MET meets the real world: design issues and clinical strategies in the Clinical Trials Network.

Carroll KM, Farentinos C, Ball SA, Crits-Christoph P, Libby B, Morgenstern J, Obert JL, Polcin D, Woody GE.

J Subst Abuse Treat. 2002 Sep;23(2):73-80. Review.

31.

A high-density genetic map of Sorghum bicolor (L.) Moench based on 2926 AFLP, RFLP and SSR markers.

Menz MA, Klein RR, Mullet JE, Obert JA, Unruh NC, Klein PE.

Plant Mol Biol. 2002 Mar-Apr;48(5-6):483-99.

PMID:
11999830
32.

Status of methamphetamine users 2-5 years after outpatient treatment.

Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W.

J Addict Dis. 2002;21(1):107-19.

PMID:
11831496
33.

The substance abuse treatment system in the U.S. What is it? What does it do? Myths and misconceptions.

Rawson RA, Obert JL.

Occup Med. 2002 Jan-Mar;17(1):27-39, iii-iv. Review.

PMID:
11726334
34.

Methamphetamine and cocaine users: differences in characteristics and treatment retention.

Rawson R, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W.

J Psychoactive Drugs. 2000 Apr-Jun;32(2):233-8.

PMID:
10908013
35.

Conducting trials in community settings: the provider perspective.

Zweben JE, Cohen JB, Obert J, Vandersloot D, Marinelli-Casey P.

J Psychoactive Drugs. 2000 Apr-Jun;32(2):193-9.

PMID:
10908007
36.

Methamphetamine abuse: issues for special populations.

Freese TE, Obert J, Dickow A, Cohen J, Lord RH.

J Psychoactive Drugs. 2000 Apr-Jun;32(2):177-82.

PMID:
10908005
37.

The matrix model of outpatient stimulant abuse treatment: history and description.

Obert JL, McCann MJ, Marinelli-Casey P, Weiner A, Minsky S, Brethen P, Rawson R.

J Psychoactive Drugs. 2000 Apr-Jun;32(2):157-64.

PMID:
10908003
38.

A high-throughput AFLP-based method for constructing integrated genetic and physical maps: progress toward a sorghum genome map.

Klein PE, Klein RR, Cartinhour SW, Ulanch PE, Dong J, Obert JA, Morishige DT, Schlueter SD, Childs KL, Ale M, Mullet JE.

Genome Res. 2000 Jun;10(6):789-807.

39.

Substance abuse treatment for "hazardous users": an early intervention.

Obert JL, Rawson RA, Miotto K.

J Psychoactive Drugs. 1997 Jul-Sep;29(3):291-8.

PMID:
9339862
40.

First angle-resolved photoelectron measurements following inner-shell resonant excitation in a singly charged ion.

Al Moussalami S, Bizau JM, Rouvellou B, Cubaynes D, Journel L, Wuilleumier FJ, Obert J, Putaux JC, Morgan TJ, Richter M.

Phys Rev Lett. 1996 Jun 10;76(24):4496-4499. No abstract available.

PMID:
10061306
41.

An intensive outpatient approach for cocaine abuse treatment. The Matrix model.

Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli-Casey PJ, Brethen PR, Ling W.

J Subst Abuse Treat. 1995 Mar-Apr;12(2):117-27.

PMID:
7623389
42.

History of sexual assault and the treatment of substance abuse disorders.

Harvey EM, Rawson RA, Obert JL.

J Psychoactive Drugs. 1994 Oct-Dec;26(4):361-7.

PMID:
7884598
43.

Addiction treatment in the mid-1990s.

Rawson RA, Marinelli-Casey P, Obert JL.

Behav Healthc Tomorrow. 1994 Sep-Oct;3(5):53-6.

PMID:
10172247
44.

The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.

Shoptaw S, Rawson RA, McCann MJ, Obert JL.

J Addict Dis. 1994;13(4):129-41.

PMID:
7734464
45.

Neurobehavioral treatment for cocaine dependency: a preliminary evaluation.

Rawson RA, Obert JL, McCann MJ, Ling W.

NIDA Res Monogr. 1993;135:92-115. Review.

PMID:
8289906
46.

Outpatient chemical dependency treatment and the managed care system: an unrealized symbiosis.

Rawson RA, Obert JL, McCann MJ, Marinelli-Casey P, Suti E.

J Ambul Care Manage. 1991 Oct;14(4):48-59. No abstract available.

PMID:
10170812
47.

First observation of photoelectron spectra emitted in the photoionization of a singly charged-ion beam with synchrotron radiation.

Bizau JM, Cubaynes D, Richter M, Wuilleumier FJ, Obert J, Putaux JC, Morgan TJ, Källne E, Sorensen S, Damany A.

Phys Rev Lett. 1991 Jul 29;67(5):576-579. No abstract available.

PMID:
10044933
48.

Psychological approaches for the treatment of cocaine dependence--a neurobehavioral approach.

Rawson RA, Obert JL, McCann MJ, Ling W.

J Addict Dis. 1991;11(2):97-119.

PMID:
1811763
49.

Cocaine abuse treatment: a review of current strategies.

Rawson RA, Obert JL, McCann MJ, Castro FG, Ling W.

J Subst Abuse. 1991;3(4):457-91. Review.

PMID:
1668230
50.

Neurobehavioral treatment for cocaine dependency.

Rawson RA, Obert JL, McCann MJ, Smith DP, Ling W.

J Psychoactive Drugs. 1990 Apr-Jun;22(2):159-71. Review.

PMID:
2197392

Supplemental Content

Support Center